$CBIO
Crescent Biopharma, Inc. Common Stock
XNAS
Why is CBIO up today? It is at $15.95 (+1.11%), and our scanner flagged it 15 times on unusual volume this month. See the catalyst behind the move, real-time alerts the moment CBIO spikes, and full due diligence on CBIO — key stats, earnings, dilution and insider activity. Free.
Get free $CBIO alerts the moment volume spikes
Our scanner flagged $CBIO 15 times in the last 30 days. Create a free account to track $CBIO, build a watchlist, and get instant unusual-volume alerts — plus 5 free premium days, no card needed.
No card · 5 premium days · join 800+ traders
Key Stats
- Price
- $15.95
- Change today
- +1.11%
- Previous close
- $15.77
- 52-week range
- $8.72 – $27.41
- Market cap
- $586M
- Institutional own.
- 72.18%
- Total held
- 95.1%
- Tradeable float
- 1.8M 5% of shares · after 23% insiders + 72% institutions
- Short interest
- 3.7M ▲ +2% vs prior · as of 2026-07-15
- Days to cover
- 9.7d
- Avg daily volume
- 217K
- Exchange
- XNAS
- 5m
- 0.1x
- 15m
- 0.1x
- 1h
- 0.5x
- 1D
- 0.2x
Get free CBIO + market alerts in your inbox
The top plays and unusual-volume catches our scanner flags, emailed to you. No account needed.
No spam. Unsubscribe anytime. Not investment advice.
Why is $CBIO up today?
CBIO is one of today's most active names, trading on unusually heavy volume (live price and day move above). Our scanner has fired 1 unusual-volume and momentum alert on CBIO today.
Likely catalystQuarterly report (10-Q), from the latest SEC filing. Read it →Analyst data via Nasdaq. Not investment advice.
Insiders
1 open-market buy1 buys, 7 sells last 3 months (10/7 over 12 months)Show 12 recent transactionsMinimize 12 recent transactions
| Insider | Action | Shares | % of position | Owns after | Value | Date |
|---|---|---|---|---|---|---|
Fairmount Funds Management Llc Director | Bought (open market) | +853K 2.3% of company | added 31% | 3.60M | $12.4M at $14.50 | Jul 16, 26 |
Brumm Joshua T Officer | Sold (automatic/other) | -42K 0.1% of company | sold 13% | 281K | $761K at $17.99 | Jun 22, 26 |
Mcneill Jonathan Officer | Sold (automatic/other) | -21K 0.06% of company | sold 13% | 139K | $370K at $17.99 | Jun 22, 26 |
Im Ellie Eunkyung Officer | Sold (automatic/other) | -1K | sold 5.2% | 22K | $22K at $17.99 | Jun 22, 26 |
Bispham Barbara Harlin Officer | Sold (automatic/other) | -1K | sold 5.9% | 19K | $22K at $17.99 | Jun 22, 26 |
Scalzo Richard William Officer | Sold (automatic/other) | -1K | sold 5.2% | 20K | $20K at $17.99 | Jun 22, 26 |
Pinkas Jan Officer | Sold (automatic/other) | -1K | sold 5.5% | 22K | $23K at $17.99 | Jun 22, 26 |
Lynch Ryan Officer | Sold (automatic/other) | -465 | sold 3.2% | 14K | $8K at $17.99 | Jun 22, 26 |
Bispham Barbara Harlin Officer | Acquired (grant/award) | +18K 0.05% of company | n/a | 18K | n/a | Dec 15, 25 |
Lynch Ryan Officer | Acquired (grant/award) | +12K 0.03% of company | n/a | 12K | n/a | Dec 15, 25 |
Im Ellie Eunkyung Officer | Acquired (grant/award) | +21K 0.06% of company | n/a | 21K | n/a | Dec 15, 25 |
Mcneill Jonathan Officer | Acquired (grant/award) | +26K 0.07% of company | added 19% | 160K | n/a | Dec 15, 25 |
Recent Form-4 filings via Nasdaq. Open-market buys are the signal worth watching. Grants and automatic (10b5-1) sells are routine. “% of position” is the share of that insider’s own holding the trade moved. Not investment advice.
Dilution watch
Active shelfRecent share offering + active shelf on file — the company raised capital and can raise more. If $CBIO runs, these filings show who may be positioned to sell new or newly-registered shares into the move.
Sourced from SEC EDGAR filings (last 9 months); terms read straight from the filing text where available. Ongoing = an at-the-market (ATM) program still selling over time or a live shelf, so it can keep diluting; Completed = a one-time priced sale that already finished. A shelf (S-3) stays effective ~3 years. Form type signals dilution capacity, not an exact share count, and we can't confirm how much of a shelf or ATM remains unused. Not investment advice.
$CBIO Sentiment
BullishBlend of news sentiment, today’s move, and community votes. Not investment advice.
$CBIO Activity
News, unusual-volume alerts, AI-trader trades and community chatter — the whole story, newest first.
CBIO stock FAQ
Why is $CBIO up today?
CBIO is one of today's most active names, trading on unusually heavy volume (live price and day move above). Our scanner has fired 1 unusual-volume and momentum alert on CBIO today.
What is the CBIO stock price today?
CBIO last traded at $15.95, up 1.11% on the day. The price and chart above update live during market hours (4 AM to 8 PM ET).
Where can I see live CBIO alerts?
The CBIO Live Alerts panel on this page streams real-time unusual volume (RVOL), momentum, halt and 200-EMA alerts from our scanner the moment they fire. Our scanner has flagged CBIO 15 times in the last 30 days.
What exchange is CBIO on?
CBIO (Crescent Biopharma, Inc. Common Stock) trades on XNAS, with a market cap of about $586M.
Is CBIO good for day trading?
That depends on your strategy and risk. Day traders look for volume, volatility and a clear trend. Use the live chart, RVOL alerts and 200-EMA context on this page to judge CBIO for yourself. This is not investment advice.
Live data from TheDesperateTrader scanner. Not investment advice.